Home/Filings/4/0001140361-23-015800
4//SEC Filing

MILLER RICHARD A MD 4

Accession 0001140361-23-015800

CIK 0001626971other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:30 PM ET

Size

5.2 KB

Accession

0001140361-23-015800

Insider Transaction Report

Form 4
Period: 2023-03-31
MILLER RICHARD A MD
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-31+800,000800,000 total
    Exercise: $0.91Exp: 2033-03-31Common Stock (800,000 underlying)
Footnotes (1)
  • [F1]The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from March 31, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file

Issuer

Corvus Pharmaceuticals, Inc.

CIK 0001626971

Entity typeother

Related Parties

1
  • filerCIK 0001031847

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:30 PM ET
Size
5.2 KB